Fix Pharma Forecasts: Common Misinterpretations of the FDA Orange Book That Distort Market Forecasts
In the high-stakes world of pharmaceutical forecasting, clarity isn’t just helpful—it’s essential. Yet, a recent analysis by DrugPatentWatch exposes a troubling trend: widespread misinterpretations of the FDA’s Orange Book that are skewing market forec…
